Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference52 articles.
1. Tumour lysis syndrome: new therapeutic strategies and classification;Cairo;Br J Haematol,2004
2. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma;Hande;Am J Med,1993
3. The tumor lysis syndrome;Howard;N Engl J Med,2011
4. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies;McBride;J Hematol Oncol,2012
5. Tumor lysis syndrome in solid tumors: an up to date review of the literature;Mirrakhimov;Rare Tumors,2014
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors;Critical Reviews in Oncology/Hematology;2024-09
2. Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis;Antioxidants;2024-04-17
3. Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia;The Lancet Oncology;2024-04
4. Acute tumor lysis syndrome — an urgent multidisciplinary problem in pediatric hematology;Russian journal of hematology and transfusiology;2024-03-19
5. Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome;Kidney and Blood Pressure Research;2024-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3